Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease

<b>Background:</b> Fabry cardiomyopathy is characterized by left ventricular hypertrophy, myocardial fibrosis, arrhythmia, and premature death. Treatment with migalastat, an oral pharmacological chaperone, was associated with a stabilization of cardiac biomarkers and a reduction in left...

Full description

Bibliographic Details

Published in:	Life
Main Authors:	Constantin Gatterer, Dietrich Beitzke, Senta Graf, Max Lenz, Gere Sunder-Plassmann, Christopher Mann, Markus Ponleitner, Robert Manka, Daniel Fritschi, Pierre-Alexandre Krayenbuehl, Philipp Kamm, Olivier Dormond, Frédéric Barbey, Pierre Monney, Albina Nowak
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Subjects:	Fabry disease cardiac imaging cardiac magnetic resonance chaperone migalastat cardiomyopathy
Online Access:	https://www.mdpi.com/2075-1729/13/5/1213